As a central extracellular signaling sensor, ERK is a key player in chemotherapy-immune resistance in cancer because it activates pro-survival pathways in tumor cells that lead to cell proliferation, migration, apoptosis resistance, differentiation, and senescence, and modulates immune responses by affecting tumor-infiltrating immune cells and tumor-immune cell interaction [25]. The gene discussed is MAPK1; the disease is neoplasm.